Information  X 
Enter a valid email address

Company Name matching 'Oxford Immunotec Global PLC'

Date
Time Source
Company
Announcement
14 Jan 2021 2:15 pm GNW   Oxford Immunotec Global PLC New Monthly Series Spotlights What 100 Physicians Find to be Critical Needs in Their Battle Against COVID-19
13 Jan 2021 2:15 pm GNW   Oxford Immunotec Global PLC Oxford Immunotec’s T-SPOT® Discovery SARS-CoV-2 Test is Used to Measure the Efficacy of Valneva’s VLA2001 COVID-19 Vaccine Candidate in a Phase I/II Clinical Study
16 Dec 2020 2:15 pm GNW   Oxford Immunotec Global PLC Oxford Immunotec Announces the Foundation of the Global T Cell Expert Consortium, Whose First Meeting Took Place This Week
10 Dec 2020 2:15 pm GNW   Oxford Immunotec Global PLC Oxford Immunotec Announces the Approval of the T-Cell Select™ Reagent Kit, Used to Automate the T-SPOT®.TB Test Workflow, for IVD Use in South Korea
02 Dec 2020 2:00 pm GNW   Oxford Immunotec Global PLC Oxford Immunotec Signs Exclusive Distributor Agreement with RIKEN Genesis, a Subsidiary of Sysmex, to Market the T-SPOT® Discovery SARS-CoV-2 Kit for the Measurement of the T cell Immune Response to SARS-CoV-2 Infection in Japan
23 Nov 2020 12:30 pm GNW   Oxford Immunotec Global PLC Oxford Immunotec to Hold a Virtual Investor Event on December 17, 2020
10 Nov 2020 2:00 pm GNW   Oxford Immunotec Global PLC Data Showing SARS-CoV-2 Reactive T Cells are Associated with Protection from COVID-19 – and Can Be Both Detected and Measured Using Oxford Immunotec’s T-SPOT® Technology – is Published by Public Health England and Oxford Immunotec
05 Nov 2020 2:00 pm GNW   Oxford Immunotec Global PLC Oxford Immunotec Files Submission to Food and Drug Administration (FDA) for the T-Cell Select™ Reagent Kit
03 Nov 2020 12:00 pm GNW   Oxford Immunotec Global PLC Oxford Immunotec Reports Third Quarter 2020 Financial Results
22 Oct 2020 10:30 am GNW   Oxford Immunotec Global PLC UK Vaccines Taskforce has Selected Oxford Immunotec as the Sole Supplier of T cell Testing for SARS-CoV-2 Specific Responses in New COVID Vaccine Trials
21 Oct 2020 9:05 pm GNW   Oxford Immunotec Global PLC Oxford Immunotec Schedules Third Quarter 2020 Earnings Release and Conference Call for November 3, 2020
22 Sep 2020 2:00 pm GNW   Oxford Immunotec Global PLC Oxford Immunotec Joins Forces with Public Health England (PHE) in a Large Clinical Trial Utilizing T-SPOT® Discovery™ SARS-CoV-2 Test
04 Aug 2020 12:00 pm GNW   Oxford Immunotec Global PLC Oxford Immunotec Reports Second Quarter 2020 Financial Results
21 Jul 2020 2:15 pm GNW   Oxford Immunotec Global PLC Oxford Immunotec Schedules Second Quarter 2020 Earnings Release and Conference Call for August 4, 2020
20 Jul 2020 2:15 pm GNW   Oxford Immunotec Global PLC Oxford Immunotec Announces Agreement with Stop TB Partnership - Global Drug Facility (GDF) to Provide Access to the T-SPOT®.TB Test for 100+ TB Burden Countries
19 May 2020 10:00 am GNW   Oxford Immunotec Global PLC Oxford Immunotec releases the T-SPOT® Discovery™ SARS-CoV-2 kit for research into measuring the T cell immune response to SARS-CoV-2, which may offer new insights into immunity to COVID-19
05 May 2020 12:00 pm GNW   Oxford Immunotec Global PLC Oxford Immunotec Reports First Quarter 2020 Financial Results
29 Apr 2020 2:15 pm GNW   Oxford Immunotec Global PLC Oxford Immunotec Schedules First Quarter 2020 Earnings Release and Conference Call for May 5, 2020
21 Apr 2020 2:15 pm GNW   Oxford Immunotec Global PLC Oxford Immunotec announces successful re-registration of the T-SPOT®.TB test in China
02 Mar 2020 12:00 pm GNW   Oxford Immunotec Global PLC Oxford Immunotec Reports Fourth Quarter and Full Year 2019 Financial Results
27 Feb 2020 2:15 pm GNW   Oxford Immunotec Global PLC Oxford Immunotec to Present at the Cowen and Company 40th Annual Health Care Conference
24 Feb 2020 2:15 pm GNW   Oxford Immunotec Global PLC Oxford Immunotec Schedules Fourth Quarter and Full Year 2019 Earnings Release and Conference Call for March 2, 2020
20 Feb 2020 2:15 pm GNW   Oxford Immunotec Global PLC Oxford Immunotec Announces New Data on the Utility of T-SPOT®.CMV in Kidney and Stem Cell Transplant
23 Jan 2020 9:00 am GNW   Oxford Immunotec Global PLC Oxford Immunotec Announces Donation in Support of Coronavirus Testing Efforts to Help Differentiate Tuberculosis from the New China Virus
06 Jan 2020 2:15 pm GNW   Oxford Immunotec Global PLC Oxford Immunotec to Present at the 38th Annual J.P. Morgan Healthcare Conference
25 Nov 2019 2:15 pm GNW   Oxford Immunotec Global PLC Oxford Immunotec to Participate in Two Investor Conferences
05 Nov 2019 12:00 pm GNW   Oxford Immunotec Global PLC Oxford Immunotec Reports Third Quarter 2019 Financial Results
22 Oct 2019 2:15 pm GNW   Oxford Immunotec Global PLC Oxford Immunotec Schedules Third Quarter 2019 Earnings Release and Conference Call for November 5, 2019
21 Aug 2019 2:15 pm GNW   Oxford Immunotec Global PLC Oxford Immunotec to Participate in Two Upcoming Investor Conferences
06 Aug 2019 12:00 pm GNW   Oxford Immunotec Global PLC Oxford Immunotec Reports Second Quarter 2019 Financial Results
18 Jul 2019 8:35 pm GNW   Oxford Immunotec Global PLC Oxford Immunotec Schedules Second Quarter 2019 Earnings Release and Conference Call for August 6, 2019
24 Jun 2019 4:35 pm GNW   Oxford Immunotec Global PLC Oxford Immunotec Appoints Patrick J. Balthrop, Sr. as Chairman
17 May 2019 2:25 pm GNW   Oxford Immunotec Global PLC Oxford Immunotec Welcomes Updated CDC Recommendations for Tuberculosis Screening and Testing of Healthcare Personnel
14 May 2019 2:20 pm GNW   Oxford Immunotec Global PLC Oxford Immunotec to Present at the UBS Global Healthcare Conference
09 May 2019 12:00 pm GNW   Oxford Immunotec Global PLC Oxford Immunotec Reports First Quarter 2019 Financial Results
25 Apr 2019 9:05 pm GNW   Oxford Immunotec Global PLC Oxford Immunotec Schedules First Quarter 2019 Earnings Release and Conference Call for May 9, 2019
28 Mar 2019 11:45 am GNW   Oxford Immunotec Global PLC Oxford Immunotec Announces New Initiative to Bring the Benefit of Modern Tuberculosis Testing to the Russian Federation
21 Mar 2019 8:01 pm GNW   Oxford Immunotec Global PLC Oxford Immunotec Announces Chief Financial Officer Transition
11 Mar 2019 8:10 pm GNW   Oxford Immunotec Global PLC Oxford Immunotec Reports Fourth Quarter and Full Year 2018 Financial Results
05 Mar 2019 2:00 pm GNW   Oxford Immunotec Global PLC Oxford Immunotec to Participate in Two Upcoming Investor Conferences
19 Feb 2019 9:45 pm GNW   Oxford Immunotec Global PLC Oxford Immunotec Schedules Fourth Quarter and Full Year 2018 Earnings Release and Conference Call for March 11, 2019
07 Jan 2019 12:00 am GNW   Oxford Immunotec Global PLC Oxford Immunotec Announces Board Approval of $100 Million Share Repurchase Program and Reaffirms Growth Expectations for Fourth Quarter 2018
02 Jan 2019 2:00 pm GNW   Oxford Immunotec Global PLC Oxford Immunotec to Present at the 37th Annual J.P. Morgan Healthcare Conference
07 Dec 2018 2:00 pm GNW   Oxford Immunotec Global PLC Oxford Immunotec Announces Regulatory Acceptance of T-Cell Select™ in China
26 Nov 2018 10:31 pm GNW   Oxford Immunotec Global PLC Oxford Immunotec to Participate in Two Investor Conferences This Week
09 Nov 2018 12:15 pm GNW   Oxford Immunotec Global PLC Oxford Immunotec Reports Third Quarter 2018 Financial Results
06 Nov 2018 10:12 pm GNW   Oxford Immunotec Global PLC Oxford Immunotec Schedules Third Quarter 2018 Earnings Release and Business Update Conference Call for November 9, 2018
31 Jul 2018 12:00 pm GNW   Oxford Immunotec Global PLC Oxford Immunotec Reports Second Quarter 2018 Financial Results
  11:55 am GNW   Oxford Immunotec Global PLC Oxford Immunotec Launches T-Cell Select™ to Enable Full Automation of the T-SPOT®.TB Test, Provides Unrivaled Sample Stability and Simplicity of Blood Collection


Company Announcements Archive »

 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t